专利检索 ap:("Jeffry G Weers" OR "Thomas E Tarara" OR "Luis A Dellamary" OR "Ernest G Schutt") AND inv:"Jean G Riess" 第 1 页

1.

发明授权
Phospholipid-based powders for drug delivery 有权

公开(公告)号：US09439862B2

公开(公告)日：2016-09-13

申请号：US14243639

申请日：2014-04-02

申请人： Jeffry G Weers , Thomas E Tarara , Luis A Dellamary , Ernest G Schutt

发明人： Jeffry G Weers , Thomas E Tarara , Luis A Dellamary , Jean G Riess , Ernest G Schutt

IPC分类号： A61K9/14 , A61K9/16 , A61K9/00 , A61K47/24 , A61K31/465 , A61K31/496 , A61K31/58 , A61K31/7036 , A61K31/7048 , A61K38/29 , A61K45/06 , A61K47/02 , A61K9/10 , A61M15/00

CPC分类号： A61K9/1617 , A61K9/0075 , A61K9/008 , A61K9/0082 , A61K9/10 , A61K9/14 , A61K9/1611 , A61K9/1694 , A61K31/465 , A61K31/496 , A61K31/58 , A61K31/7036 , A61K31/7048 , A61K38/29 , A61K45/06 , A61K47/02 , A61K47/24 , A61M15/0065 , A61M2205/3306

摘要： Phospholipid based powders for drug delivery applications are disclosed. The powders comprise a polyvalent cation in an amount effective to increase the gel-to-liquid crystal transition temperature of the particle compared to particles without the polyvalent cation. The powders are hollow and porous and are preferably administered via inhalation.